DK172076B1 - Derivater af 4-benzyl-1-(2H)-phthalazinon, fremgangsmåde til fremstilling heraf, forbindelserne til terapeutisk anvendelse, anvendelse af forbindelserne til fremstilling af lægemidler, lægemidler indeholdende forbindelserne samt fremgangsmåde til fremstilling af sådanne lægemidler - Google Patents

Derivater af 4-benzyl-1-(2H)-phthalazinon, fremgangsmåde til fremstilling heraf, forbindelserne til terapeutisk anvendelse, anvendelse af forbindelserne til fremstilling af lægemidler, lægemidler indeholdende forbindelserne samt fremgangsmåde til fremstilling af sådanne lægemidler Download PDF

Info

Publication number
DK172076B1
DK172076B1 DK536486A DK536486A DK172076B1 DK 172076 B1 DK172076 B1 DK 172076B1 DK 536486 A DK536486 A DK 536486A DK 536486 A DK536486 A DK 536486A DK 172076 B1 DK172076 B1 DK 172076B1
Authority
DK
Denmark
Prior art keywords
group
alkyl
compounds
alkylamino
alkoxy
Prior art date
Application number
DK536486A
Other languages
Danish (da)
English (en)
Other versions
DK536486D0 (da
DK536486A (da
Inventor
Juergen Engel
Gerhard Scheffler
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of DK536486D0 publication Critical patent/DK536486D0/da
Publication of DK536486A publication Critical patent/DK536486A/da
Application granted granted Critical
Publication of DK172076B1 publication Critical patent/DK172076B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK536486A 1985-11-11 1986-11-10 Derivater af 4-benzyl-1-(2H)-phthalazinon, fremgangsmåde til fremstilling heraf, forbindelserne til terapeutisk anvendelse, anvendelse af forbindelserne til fremstilling af lægemidler, lægemidler indeholdende forbindelserne samt fremgangsmåde til fremstilling af sådanne lægemidler DK172076B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3539873 1985-11-11
DE3539873 1985-11-11

Publications (3)

Publication Number Publication Date
DK536486D0 DK536486D0 (da) 1986-11-10
DK536486A DK536486A (da) 1987-05-12
DK172076B1 true DK172076B1 (da) 1997-10-13

Family

ID=6285623

Family Applications (1)

Application Number Title Priority Date Filing Date
DK536486A DK172076B1 (da) 1985-11-11 1986-11-10 Derivater af 4-benzyl-1-(2H)-phthalazinon, fremgangsmåde til fremstilling heraf, forbindelserne til terapeutisk anvendelse, anvendelse af forbindelserne til fremstilling af lægemidler, lægemidler indeholdende forbindelserne samt fremgangsmåde til fremstilling af sådanne lægemidler

Country Status (20)

Country Link
US (1) US4841047A (ja)
EP (1) EP0222191B1 (ja)
JP (1) JPH0780871B2 (ja)
CN (1) CN86107627A (ja)
AT (1) ATE60598T1 (ja)
AU (1) AU593593B2 (ja)
CA (1) CA1295613C (ja)
DD (1) DD263058A5 (ja)
DE (1) DE3677322D1 (ja)
DK (1) DK172076B1 (ja)
ES (1) ES2031813T3 (ja)
FI (1) FI88504C (ja)
GR (1) GR3001412T3 (ja)
HU (1) HU196793B (ja)
IE (1) IE59056B1 (ja)
IL (1) IL80560A0 (ja)
NO (1) NO864474L (ja)
PT (1) PT83713B (ja)
SU (1) SU1454251A3 (ja)
ZA (1) ZA868531B (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64051B1 (en) * 1987-11-13 1995-06-28 Asta Medica Ag Azelastine embonate process for its preparation and pharmaceutical preparations which contain azelastine embonate as active substance
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
FR2643373B1 (fr) * 1989-01-10 1993-12-31 Adir Cie Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
ATE107643T1 (de) * 1989-05-05 1994-07-15 Asta Medica Ag Salze des azelastins mit verbesserter löslichkeit.
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
EP0561166A1 (de) * 1992-03-17 1993-09-22 ASTA Medica Aktiengesellschaft Dosieraerosole enthaltend den Wirkstoff D-18024 und verwandte Strukturen
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US7151102B2 (en) * 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
EP1501822B1 (en) * 2002-04-30 2010-12-15 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US7449464B2 (en) * 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
NZ555501A (en) 2004-11-24 2010-01-29 Medpointe Healthcare Inc Compositions comprising azelastine and methods of use thereof
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
US20090105225A1 (en) * 2006-04-20 2009-04-23 Glaxo Group Limited 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
WO2007144639A1 (en) * 2006-06-15 2007-12-21 Kudos Pharmaceuticals Limited 2 -oxybenzamide derivatives as parp inhibitors
CN101484436A (zh) * 2006-06-15 2009-07-15 库多斯药物有限公司 作为parp抑制剂的2-氧基杂芳基酰胺衍生物
EP2035380A2 (en) * 2006-06-15 2009-03-18 Kudos Pharmaceuticals Limited Parp inhibitors
TWI404716B (zh) * 2006-10-17 2013-08-11 Kudos Pharm Ltd 酞嗪酮（ｐｈｔｈａｌａｚｉｎｏｎｅ）衍生物
TW200831493A (en) * 2006-12-20 2008-08-01 Glaxo Group Ltd Compounds
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
JP2010539149A (ja) 2007-09-14 2010-12-16 アストラゼネカ アクチボラグ フタラジノン誘導体
US20100216799A1 (en) * 2007-10-11 2010-08-26 Glaxo Group Limited Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
AU2008313467B2 (en) * 2007-10-17 2013-08-29 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-1-carbonyl) -4 -fluoro-benzyl] -2H-phthalazin-1-one
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
JP5524220B2 (ja) 2008-10-07 2014-06-18 アストラゼネカ・ユーケイ・リミテッド 医薬配合物５１４
UY32790A (es) * 2009-07-15 2011-02-28 Astrazeneca Ab Compuesto de ftalazinona
CN113956239A (zh) * 2021-10-28 2022-01-21 昆明源瑞制药有限公司 一种盐酸氮卓斯汀及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017411A (en) * 1962-01-16 New substituted phthalazones and proc-
DE2114884A1 (de) * 1971-03-27 1972-10-12 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des 1(2H)-Phthalazinons
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
DE3530793A1 (de) * 1984-09-14 1986-03-27 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld Substituierte benzylphthalazinon-derivate
ATE49205T1 (de) * 1984-09-14 1990-01-15 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.

Also Published As

Publication number Publication date
SU1454251A3 (ru) 1989-01-23
FI864555A0 (fi) 1986-11-10
GR3001412T3 (en) 1992-09-25
NO864474D0 (no) 1986-11-10
CA1295613C (en) 1992-02-11
FI88504B (fi) 1993-02-15
PT83713A (de) 1986-12-01
JPS62114987A (ja) 1987-05-26
IE862960L (en) 1987-05-11
PT83713B (pt) 1989-06-30
EP0222191A1 (de) 1987-05-20
DD263058A5 (de) 1988-12-21
IE59056B1 (en) 1993-12-15
DK536486D0 (da) 1986-11-10
ATE60598T1 (de) 1991-02-15
CN86107627A (zh) 1987-07-15
FI88504C (fi) 1993-05-25
HU196793B (en) 1989-01-30
FI864555A (fi) 1987-05-12
EP0222191B1 (de) 1991-01-30
ES2031813T3 (es) 1993-01-01
DK536486A (da) 1987-05-12
AU6498286A (en) 1987-05-14
US4841047A (en) 1989-06-20
NO864474L (no) 1987-05-12
IL80560A0 (en) 1987-02-27
AU593593B2 (en) 1990-02-15
JPH0780871B2 (ja) 1995-08-30
HUT42084A (en) 1987-06-29
DE3677322D1 (de) 1991-03-07
ZA868531B (en) 1987-07-29

Similar Documents

Publication Publication Date Title
DK172076B1 (da) Derivater af 4-benzyl-1-(2H)-phthalazinon, fremgangsmåde til fremstilling heraf, forbindelserne til terapeutisk anvendelse, anvendelse af forbindelserne til fremstilling af lægemidler, lægemidler indeholdende forbindelserne samt fremgangsmåde til fremstilling af sådanne lægemidler
KR870000354B1 (ko) 피리딘-2-에테르 또는 피리딘-2-티오에테르의 제조방법
DE69013607T2 (de) Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
IL152531A (en) History of 8 - (3 - carboxyamido - 3 - phenylpropyl) - 3 - (isopropyl - 5 - methyl - H4 - 4, 2, 1 – triazole - 4 - il) - tropane, drugs containing them, their preparation and some new intermediate compounds
JPH0739387B2 (ja) 新規１−ベンジル−アミノアルキル−ピロリジノン化合物及びその製造方法
JP2017141274A (ja) ピロール誘導体の結晶
JPH0222758B2 (ja)
JPH0240657B2 (ja) 3*44jihidorokarubosuchirirujudotai
CS240974B2 (en) Production method of n formyl a n-hydroxymethyl-3-phenoxy-1-azetidincarboxamides
AU2011243393B2 (en) Novel benzamide derivatives
JP2018502075A (ja) 抗ヒスタミン剤としての新規ベンゾイミダゾール誘導体
JPH0517904B2 (ja)
DE60107056T2 (de) Benzoxazolderivate als tnf und pde iv inhibitoren
EP0089028A1 (de) Neue Theophyllin-Derivate und Verfahren zu ihrer Herstellung
JP3057095B2 (ja) イサチン誘導体、その製造方法及びその使用方法
KR20210024531A (ko) Trk 수용체의 조절제로서의 4-치환된 페닐-1,3,5-트리아진 유도체
JPS5980657A (ja) ３−フエノキシ−１−アゼチジンカルボキサミド、その製造方法及びそれからなる鎮痙剤
DE3813531A1 (de) Neue 2-aminoalkyl-4-benzyl-1-(2h)-phthalazinon-derivate
KR20130108326A (ko) 효능이 강한 ｈｃｖ 억제제의 고체 상태 형태
WO1985000169A1 (en) 1,4-dihydropyridine derivatives, production thereof and pharmaceutical preparations containing them
DE3634942A1 (de) Neue 4-benzyl-1-(2h)-phthalazinon-derivate
NO316889B1 (no) Vannfri krystallform av R(-)-N-(4,4-di(3-metyltien-2-yl)but-3-enyl) -nipekotinsyrehydrokloridet, fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter et slikt krystallinsk salt, og anvendelse av et slikt krystallinsk salt til fremstill
DE2819873A1 (de) N-phenyl-n-(4-piperidinyl)-amide, verfahren zu deren herstellung und deren verwendung als analgetika
RU2727974C2 (ru) Соли 1-(4-(2-((1-(3,4-дифторфенил)-1н-пиразол-3-ил)метокси)этил)пиперазин-1-ил)этанона
NO881899L (no) Nye 2-aminoalkyl-4-benzyl-1-(2h)-ftalazino-derivater.